Personalized Testing and Supplements Market Size, Share and Trends 2025 to 2034

Revenue, 2024

USD 5.18 Bn

Forecast Year, 2034

USD 7.74 Bn

CAGR, 2025 - 2034

16.22%

Report Coverage

Global

What is the Personalized Testing and Supplements Market Size?

The global personalized testing and supplements market size is calculated at USD 5.39 billion in 2025 and is predicted to increase from USD 5.61 billion in 2026 to approximately USD 7.74 billion by 2034, expanding at a CAGR of 16.22% from 2025 to 2034. The market growth is attributed to increasing consumer demand for personalized health solutions and wellness analytics services.

Market Highlights

• The North America segment held a dominant presence in the market in 2024, accounting for an estimated 40% market share.
• The Asia Pacific segment is expected to grow at the fastest CAGR of in the market during the 20% from 2025 to 2034.
• By product type, the nutrition supplements segment accounted for a considerable share of 65% in 2024.
• By product type, the personalized testing segment is expanding at a strong CAGR from 2025 to 2034.
• By service type, the genetic testing services segment led the market, accounting for an estimated 40% market share in 2024.
• By service type, the consultation & personalized recommendations segment is expanding at a solid CAGR from 2025 to 2034.
• By delivery format, the oral supplements segment contributed the biggest market share of 55% in 2024.
• By delivery format, the functional foods & beverages segment is anticipated to grow with the highest CAGR between 2025 and 2034.
• By application, the general wellness segment dominated the market, accounting for an estimated 50% market share in 2024.
• By application, the sports and wellness segment is projected to grow at a notable CAGR from 2025 to 2034.
• By end-user, the individual consumers segment held the major market share of 60% in 2024.
• By end-user, the healthcare & clinics segment is expected to grow at a strong CAGR from 2025 to 2034.

Market Overview

Increasing consumer health consciousness and preventative-care orientations as more consumers demand nutrition and testing solutions that are specific to their biology and not the one-size-fits-all supplements. The technological basis of this is genetic sequencing, microbiome studies, metabolic biomarker studies, and artificial intelligence-driven algorithms.

That combines these data with lifestyle data to provide personalized testing data and supplement suggestions. NIH is committing US$170 million to the NIH Nutrition for Precision Health program to recruit 10,000 participants and create algorithms to predict personal responses to food and dietary habits using AI and microbiome technology. Furthermore, the fastening nature of wearable biosensors , mobile health apps, and AI analytics to provide real-time dietary or supplement feedback further facilitates the personalized testing market.

Impact of Artificial Intelligence on the Personalized Testing & Supplements Market

Artificial intelligence (AI) is transforming genetic, metabolic, and lifestyle data into practical health-sensitive information. Firms are combining AI-based analytics with testing systems to decipher DNA sequences, microbiome compositions, and biomarker concentrations with greater accuracy than before. Furthermore, the nutritionists and health-technology companies can use this technology to create an individualized type of supplement targeted at addressing a particular deficiency.

Personalized Testing and Supplements Market Growth Factors

• Rising Consumer Awareness of Preventive Health: Growing public understanding of nutrition– genomics links is fuelling demand for DNA-based testing and customized supplement solutions.
• Expanding Integration of AI and Data Analytics: Advancements in artificial intelligence are driving more precise health assessments and boosting the adoption of data-driven personalization platforms.
• Growing Influence of Digital Health Ecosystems: The increasing use of mobile health apps and connected wearables is propelling continuous monitoring and individualized supplement recommendations.
• Surging Investment in Nutrigenomics Research: Rising funding from public health agencies and private investors is fuelling breakthroughs in genotype-based nutrition science.

Global Insights & Metrics Driving the Personalized Health Revolution

• In 2022, the United States accounted for over $465 million in revenue from DTC genetic testing, covering ancestry and health risk assessments. The U.S. leads in lab infrastructure and consumer trust in genomics. This revenue demonstrates strong market penetration and adoption among health-conscious populations.
• As of November 2023, there were approximately 197,779 genetic tests available globally, with over 129,000 tests offered in the United States alone. This reflects the rapid expansion of genetic testing services worldwide
• A study in 2023 revealed that 289 laboratories provided information on tests offered, with 138 (47.8%) offering only panel testing throughout their enrollment. This highlights the scale and specialization of clinical laboratories in genetic testing
• As of 2023, there are over 10,250 genetic counselors in more than 45 countries, indicating a growing workforce to support the increasing demand for genetic testing services
• The EU has established the In Vitro Diagnostic Regulation (IVDR), which came into effect in May 2022. This regulation requires that all in vitro diagnostic devices, including genetic tests, undergo a conformity assessment and be CE marked before being placed on the market
• In 2025, genetic testing services will be regulated by the Indian Council of Medical Research (ICMR). The ICMR has issued guidelines for genetic testing, emphasizing the need for informed consent and the involvement of qualified healthcare professionals in the testing process
• A study published in 2023 reported that, as of November 2022, there were 129,624 genetic tests available in the United States and 197,779 globally.
• In 2024, global health app downloads reached 388 million, reflecting growing consumer adoption of digital health tools. Consumers increasingly use apps to track genetic test results, supplements, and personalized health insights. This growth is driven by the proliferation of smartphones and wearable devices.
• In 2023, users spent a total of $377 million on healthcare apps, a 19% increase from the previous year. This spending includes subscriptions, premium features, and integration with personalized supplement services. The rise in app monetization indicates strong consumer willingness to invest in digital health solutions.

Market Scope

Personalized Testing & Supplements Market – Regulatory Landscape

Personalized Testing and Supplements MarketSegment Insights

[[segment_insights]]

Personalized Testing and Supplements MarketRegional Insights

[[regional_insights]]

Personalized Testing and Supplements Market Value Chain

[[value_chain]]

Personalized Testing and Supplements Market Companies

[[market_company]]

Top Vendors in Gel Documentation Systems Market & Their Offerings

• Viome Life Sciences: Viome is a leader in AI-driven microbiome and gene expression testing, offering personalized nutrition and supplement recommendations based on individual biological data. Its proprietary metatranscriptomic sequencing technology analyzes gut and oral microbiome activity to create custom supplement formulations under its Precision Supplements line. Viome's strong research partnerships and focus on preventive health position it as a top innovator in precision wellness.
• DSM Nutritional Products AG: A global leader in nutritional ingredients and life sciences, DSM combines bioscience expertise and data-driven innovation to develop personalized supplement solutions. The company's portfolio includes vitamins, lipids, probiotics , and specialty nutrients, supported by digital tools and diagnostics for individualized nutrition. DSM's merger with Firmenich to form DSM-Firmenich further strengthens its position in holistic health and wellness personalization.
• Thorne HealthTech: Thorne offers personalized health testing and supplement solutions, integrating biomarker and genetic insights through its proprietary Thorne Health Intelligence platform. The company's product range includes personalized vitamins, performance supplements, and at-home diagnostic kits. Thorne's collaboration with Mayo Clinic and its focus on clinical validation make it a trusted brand in precision nutrition.
• Pharmavite LLC: Parent company of the well-known Nature Made brand, Pharmavite has entered the personalized nutrition space through data-driven supplement offerings and digital health integrations. The company leverages its strong manufacturing base and research expertise to deliver customized vitamin and nutrient packs, aligning with evolving consumer demand for tailored wellness.
• Baze: Baze provides personalized micronutrient solutions through at-home blood testing and algorithm-based supplement recommendations. Its model combines nutrient deficiency analysis with individualized supplement delivery. Baze emphasizes clinical accuracy and adaptive nutrition, catering to health-conscious consumers seeking measurable results.
• GNC Holdings, Inc.: A global retailer of health and wellness products, GNC has pivoted toward personalization through DNA- and lifestyle-based supplement plans. Its partnerships and tech integrations enable data-backed product recommendations, complementing its wide retail presence and established brand trust.
• The Vitamin Shoppe: The Vitamin Shoppe has integrated personalized wellness into its retail and digital strategy through customized supplement regimens, DNA testing partnerships, and subscription models. The company's omnichannel presence allows it to blend e-commerce personalization tools with expert in-store consultations.
• Nestle Health Science: Nestlé Health Science leads the personalized nutrition and medical nutrition sector through brands like Persona Nutrition, Garden of Life, and Vital Proteins. The company leverages genetic and lifestyle data to tailor supplement and meal solutions, reflecting its strategic expansion into precision health. Its deep R&D capabilities and acquisitions have positioned it as a global powerhouse in personalized wellness.
• Vitaminpacks, Inc.: Acquired by Nestlé Health Science, Persona Nutrition provides AI-powered, questionnaire-based personalized vitamin packs delivered via subscription. Its platform evaluates health goals, medications, and dietary habits to generate custom supplement regimens. Persona's technology-driven model exemplifies scalable personalization in the supplements industry.
• myDNA: myDNA offers genetic testing-based nutrition and fitness plans, translating DNA insights into actionable supplement and dietary recommendations. The company's direct-to-consumer platform integrates nutrigenomics and digital coaching, empowering users to make informed wellness choices.
• LifeNome: LifeNome provides AI-based genomic analysis for personalized nutrition, wellness, and skincare. Its Epitrace™ platform analyzes hundreds of genetic markers to recommend supplements and health strategies. The company also partners with health brands to enable embedded personalization technology.
• Everlywell: Everlywell specializes in at-home diagnostic testing, including metabolic and micronutrient tests that guide supplement and diet plans. Through its digital health platform, the company connects users to lab-based insights for personalized nutrition, positioning itself as a key enabler of data-driven wellness.
• Nutrisystem: Nutrisystem integrates personalized meal and supplement plans with metabolic and lifestyle data, offering solutions for weight management and metabolic health. Its transition toward digital personalization and adaptive diet programs enhances its competitiveness in the health optimization market.
• Nutrigenomix Inc.: A pioneer in genetic testing for personalized nutrition, Nutrigenomix provides evidence-based DNA tests that guide diet and supplement recommendations. Its platform is used by healthcare professionals and dietitians globally to enable clinical-grade personalized nutrition advice.
• Orig3n: Orig3n offers DNA-based wellness and nutrition tests that help consumers understand their genetic predispositions related to metabolism, vitamins, and exercise response. Its consumer-friendly kits and genetic insights apps make it accessible for entry-level personalization.
• Anatolia Nutrition: An emerging player focused on nutrigenetic supplements and metabolic testing, Anatolia Nutrition combines biomarker analysis with regionally tailored nutrition plans, targeting the Middle Eastern and European personalized wellness markets.
• Nutritional Growth Solutions: Focused on pediatric growth and development, Nutritional Growth Solutions offers personalized nutritional supplements designed using clinical research and child growth data. The company bridges clinical nutrition and personalization, addressing a niche market segment.
• Nutritional Genomics: Nutritional Genomics develops genomic and metabolomic-based diagnostic tools that enable supplement manufacturers and clinics to deliver customized nutrition interventions. Its research-driven approach integrates molecular biology and AI analytics for data-backed personalization.

Personalized Testing and Supplements MarketSegments Covered in the Report

[[segment_covered]]